The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.7M data for 1.2M Compounds and 9.0K Targets. Of those, 1,244K data for 572K Compounds and 4.4K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations.EBI
National and Kapodistrian University of Athens
Inhibition of secreted phospholipases A2 by 2-oxoamides based ona-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.EBI
University of Athens
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.EBI
University of Washington
Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.EBI
University of Washington
Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.EBI
Université
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.EBI
Cnrs Umr 7175
The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding.EBI
University of Washington
1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.EBI
Universit£
Design of Selective sPLAEBI
Astrazeneca
Discovery of a Series of Indole-2 Carboxamides as Selective Secreted Phospholipase AEBI
Astrazeneca